Evidence map›Paper›PMID 34830054›Full record

ArticleInternational journal of molecular sciences2021

The Fusion of

Bijay P Dhungel, Geoffray Monteuuis, Caroline Giardina, Mehdi S Tabar, Yue Feng, Cynthia Metierre, Sarah Ho, Rajini Nagarajah, Angela R M Fontaine, Jaynish S Shah and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Transcriptional Regulation and Its Misregulation in Human Diseases.International journal of molecular sciences · 2023
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Bijay P DhungelGene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.ORCID 0000-0001-5130-5224
Geoffray MonteuuisDepartment of Biochemistry and Developmental Biology, University of Helsinki, 00014 Helsinki, Finland.ORCID 0000-0001-7193-7771
Caroline GiardinaGene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.ORCID 0000-0002-3681-057X
Mehdi S TabarGene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Yue FengGene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Cynthia MetierreGene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Sarah HoGene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Rajini NagarajahGene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Angela R M FontaineCentenary Imaging and Sydney Cytometry Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Jaynish S ShahGene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Divya GokalGene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.
Charles G BaileyGene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.ORCID 0000-0002-4725-7829
Ulf SchmitzDepartment of Molecular & Cell Biology, College of Public Health, Medical & Vet Sciences, James Cook University, Townsville, QLD 4811, Australia.ORCID 0000-0001-5806-4662
John E J RaskoGene and Stem Cell Therapy Program Centenary Institute, The University of Sydney, Camperdown, NSW 2050, Australia.ORCID 0000-0003-2975-807X
The University of Sydney · AUJames Cook University · AUUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chimeric RNAs are often associated with chromosomal rearrangements in cancer. In addition, they are also widely detected in normal tissues, contributing to transcriptomic complexity. Despite their prevalence, little is known about the characteristics and functions of chimeric RNAs. Here, we examine the genetic structure and biological roles of

Indexed as

Gene FusionTrans-SplicingAntineoplastic AgentsApoptosisCell DifferentiationCell LineCytarabineHumansLectins, C-TypeLeukemia, MyeloidMicroRNAsMutant Chimeric ProteinsReceptors, MitogenTranscriptional ActivationAntineoplastic AgentsCLEC12A protein, humanCytarabineLectins, C-TypeMicroRNAsMIR223, humanMutant Chimeric ProteinsReceptors, Mitogenalternative splicingCCL1chimeric RNAschronic myeloid leukemiaC-type lectinFusion RNAs encoding proteinfusion transcriptlinc-223miR-223 host genemyeloid cell differentiationtrans-splicing

Identifiers

PMID34830054
PMCPMC8625150
OpenAlexW3213413476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.